Home > News > Altair Nanotechnologies and Spectrum Pharmaceuticals Agree to Settlement
June 8th, 2006
Altair Nanotechnologies and Spectrum Pharmaceuticals Agree to Settlement
Abstract:
Altair Nanotechnologies, Inc. (NASDAQ: ALTI), announced today it will receive 100,000 shares of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) stock for a milestone payment and an additional 40,000 shares for product development improvements, with a total approximate value of $550,000, following a mutually agreed upon resolution to arbitration proceedings involving the two companies.
Source:
businesswire
Bookmark:
| Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over 14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||